| Alginate encapsulant incorporating CXCL12 supports long-term allo-and xenoislet transplantation without systemic immune suppression T Chen, J Yuan, S Duncanson, ML Hibert, BC Kodish, G Mylavaganam, ... American Journal of Transplantation 15 (3), 618-627, 2015 | 114 | 2015 |
| Long-acting protein drugs for the treatment of ocular diseases JG Ghosh, AA Nguyen, CE Bigelow, S Poor, Y Qiu, N Rangaswamy, ... Nature communications 8 (1), 14837, 2017 | 51 | 2017 |
| AAV-mediated RLBP1 gene therapy improves the rate of dark adaptation in Rlbp1 knockout mice VW Choi, CE Bigelow, TL McGee, AN Gujar, H Li, SM Hanks, ... Molecular therapy Methods & clinical development 2, 2015 | 28 | 2015 |
| Non-invasive molecular tracking method that measures ocular drug distribution in non-human primates G Normand, M Maker, J Penraat, K Kovach, JG Ghosh, C Grosskreutz, ... Communications biology 3 (1), 16, 2020 | 8 | 2020 |
| Amount of mononuclear phagocyte infiltrate does not predict area of experimental choroidal neovascularization (CNV) A Will-Orrego, Y Qiu, ES Fassbender, S Shen, J Aranda, N Kotagiri, ... Journal of Ocular Pharmacology and Therapeutics 34 (7), 489-499, 2018 | 6 | 2018 |
| A comparison of the effects of subretinal injection of scAAV2-CMV-GFP on retinal structure, visual function, and GFP expression by two injectors H Li, S Poor, C Bigelow, V Choi, S Hanks, J Vrouvlianis, M Maker, S Louie, ... Investigative Ophthalmology & Visual Science 54 (15), 2740-2740, 2013 | 1 | 2013 |
| Retinal Dystrophy Associated With RLBP1 Retinitis Pigmentosa: A Five-Year Prospective Natural History Study M Burstedt, JH Whelan, JS Green, K Holopigian, C Spera, E Greco, ... Investigative Ophthalmology & Visual Science 64 (13), 42-42, 2023 | | 2023 |
| Validation of 3D volumetry for a novel anti-angiogenic therapy of neovascular age-related macular degeneration G Normand, EH Souied, B Lay, R Danno, R Blanco-Garavito, P Charrard, ... Investigative Ophthalmology & Visual Science 58 (8), 1282-1282, 2017 | | 2017 |
| Longitudinal evaluation of optical coherence tomography and color fundus photography over 2 year follow up in patients with RLBP1 retinitis pigmentosa JH Whelan, G Normand, M Maker, M Burstedt, J Green, M Wald, Z Su, ... Investigative Ophthalmology & Visual Science 58 (8), 3255-3255, 2017 | | 2017 |
| Impaired alternative complement pathway function does not protect against light-induced retinopathy in mice SM Hanks, J Vrouvlianis, B Leehy, M Crowley, M Maker, SM Liao, ... Investigative Ophthalmology & Visual Science 56 (7), 3553-3553, 2015 | | 2015 |
| Progressive loss of sensitivity to anti-VEGF and anti-PDGFRb treatment with advancing corneal neovascularization A Jensen, R Cepeda, M Maker, M Twarog, L Johnson, S Azarian Investigative Ophthalmology & Visual Science 56 (7), 689-689, 2015 | | 2015 |
| Quantifying Hyperglycemia-Associated Retinal Changes via Optical Coherence Tomography in Mice with Streptozotocin-Induced Diabetes S Hanks, J Vrouvlianis, B Leehy, S Louie, MP Maker, NV Rangaswamy, ... Investigative Ophthalmology & Visual Science 55 (13), 4931-4931, 2014 | | 2014 |
| Recombinant human vascular endothelial growth factor165 (VEGF) derived from different expression systems does not affect in vitro, but does impact in vivo activity profiles Y Qiu, CE Bigelow, L Ferrara, S Shen, MP Maker, E Fassbender, Y Kim, ... Investigative Ophthalmology & Visual Science 55 (13), 600-600, 2014 | | 2014 |
| Antagonism of PDGFRβ Inhibits Pericyte Recruitment in a Mouse Model of Corneal Neovascularization A Jensen, R Cepeda, M Maker, C Bigelow, J Ghosh, G Li, P D'Amore, ... Investigative Ophthalmology & Visual Science 54 (15), 4630-4630, 2013 | | 2013 |
| Development of a Rabbit Model to Assess Anti-Angiogenic Therapies that Modulate Human VEGF-Mediated Retinal Vessel Pathology CE Bigelow, S Poor, Y Qiu, SM Hanks, M Maker, E Fassbender, S Shen, ... Investigative Ophthalmology & Visual Science 52 (14), 1384-1384, 2011 | | 2011 |
| CXCL12 Coating Causes Effector T Cell Chemorepulsion from and T Regulatory Cell Chemoattraction to Allogeneic Islet Grafts and Significantly Delays Their Rejection. T Chen, G Mylvaganam, M Maker, J Markmann, DH Sachs, ... AMERICAN JOURNAL OF TRANSPLANTATION 11, 162-162, 2011 | | 2011 |
| Coating of Skin Allografts or Integra with CXCL12 Significantly Delays Rejection as a Result of Recipient T Cell Chemorepulsion. T Chen, GH Mylvaganam, M Maker, ZP Thompson, X Xu, F Jaafar, ... AMERICAN JOURNAL OF TRANSPLANTATION 9, 557-557, 2009 | | 2009 |
